Nonmedical Prescription Opioid Use among a Sample of College Students: Prevalence and Predictors.

Lisa L Weyandt, Bergljót Gyda Gudmundsdottir, Emily Shepard, Leslie Brick, Ashley Buchanan, Christine Clarkin, Alyssa Francis, Marisa Marraccini
Author Information
  1. Lisa L Weyandt: University of Rhode Island, Kingston, RI 02881, USA.
  2. Bergljót Gyda Gudmundsdottir: University of Iceland, 107 Reykjavík, Iceland. ORCID
  3. Emily Shepard: University of Rhode Island, Kingston, RI 02881, USA.
  4. Leslie Brick: Brown University, Providence, RI 02912, USA.
  5. Ashley Buchanan: University of Rhode Island, Kingston, RI 02881, USA.
  6. Christine Clarkin: University of Rhode Island, Kingston, RI 02881, USA. ORCID
  7. Alyssa Francis: University of Rhode Island, Kingston, RI 02881, USA.
  8. Marisa Marraccini: University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ORCID

Abstract

Nonmedical use of prescription opioid medication (NMPO) in the United States is a public health crisis, resulting in high rates of emergency room visits, morbidity, and mortality. The purpose of this study was to explore prevalence estimates and correlates of NMPO among a convenience sample of college students in the northeast and southeast regions of the US to help generate directions for future research. Motivations for misuse, age of onset, access, concomitant substance use, and individual factors were investigated among a sample of undergraduate students from two universities. Participants ( = 847) completed a battery of various self-report measures. Findings revealed that 7.7% (Southeastern University) and 12.8% of students (Northeastern University) reported lifetime NMPO, whereas past-month NMPO was reported by 0.8% and 0.9% of participants, respectively. Lifetime history of regularly using alcohol, nonmedical use of benzodiazepine medication, nonmedical use of prescription stimulants, symptoms of depression and anxiety, and executive functioning (i.e., metacognition and behavioral regulation) were significantly related to lifetime history of NMPO in this college sample. These findings offer several potential subsequent lines of investigation regarding the associations between various demographic and psychological factors and NMPO. Future research is needed to help identify college students who are at risk of NMPO.

Keywords

References

  1. Int J Drug Policy. 2017 Aug;46:1-6 [PMID: 28511053]
  2. Pain Physician. 2019 May;22(3):229-240 [PMID: 31151331]
  3. Clin J Pain. 2018 Sep;34(9):878-884 [PMID: 29505419]
  4. Prev Chronic Dis. 2020 May 21;17:E37 [PMID: 32441640]
  5. Psychiatry Res. 2020 May;287:112469 [PMID: 31279491]
  6. J Addict Med. 2016 Nov/Dec;10(6):408-413 [PMID: 27559846]
  7. Am J Prev Med. 2019 Oct;57(4):533-539 [PMID: 31443955]
  8. BMJ. 2015 Jun 10;350:h2698 [PMID: 26063215]
  9. Res Q Exerc Sport. 2015 Jun;86(2):205-11 [PMID: 25514090]
  10. Addict Sci Clin Pract. 2018 Apr 18;13(1):14 [PMID: 29669599]
  11. Psychiatr Serv. 2013 Oct;64(10):952-60 [PMID: 23852272]
  12. J Biomed Inform. 2009 Apr;42(2):377-81 [PMID: 18929686]
  13. Addict Behav. 2018 Oct;85:94-99 [PMID: 29883856]
  14. Subst Abuse. 2017 Sep 25;11:1178221817733736 [PMID: 28979131]
  15. Addict Behav. 2014 Dec;39(12):1798-803 [PMID: 25123349]
  16. Alcohol Clin Exp Res. 2016 Sep;40(9):1913-25 [PMID: 27488763]
  17. Qual Life Res. 2009 Sep;18(7):873-80 [PMID: 19543809]
  18. Drug Alcohol Depend. 2015 Apr 1;149:25-30 [PMID: 25666362]
  19. J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S107-S112.e2 [PMID: 28063773]
  20. Psychopharmacology (Berl). 2012 Jan;219(2):673-83 [PMID: 21922168]
  21. J Clin Epidemiol. 2016 May;73:89-102 [PMID: 26952842]
  22. MMWR Morb Mortal Wkly Rep. 2019 Aug 30;68(34):737-744 [PMID: 31465320]
  23. Addict Behav. 2014 Jul;39(7):1176-82 [PMID: 24727278]
  24. Neuropsychology. 2019 Feb;33(2):212-221 [PMID: 30589284]
  25. J Hosp Med. 2019 Jul 24;14(12):737-745 [PMID: 31339840]
  26. Addict Behav. 2018 Dec;87:24-32 [PMID: 29940388]
  27. Cogn Behav Ther. 2018 Sep;47(5):372-382 [PMID: 29482460]
  28. J Addict. 2013;2013:680705 [PMID: 24826367]
  29. MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427 [PMID: 30605448]
  30. Psychol Addict Behav. 2014 Dec;28(4):1290-6 [PMID: 25180561]
  31. J Urban Health. 2017 Feb;94(1):115-124 [PMID: 28083726]
  32. Soc Psychiatry Psychiatr Epidemiol. 2015 May;50(5):713-24 [PMID: 25427665]
  33. Arch Gen Psychiatry. 2001 Nov;58(11):1065-71 [PMID: 11695954]
  34. Drug Alcohol Depend. 2018 Sep 1;190:62-71 [PMID: 29981943]
  35. Am J Addict. 2019 Feb;28(2):111-118 [PMID: 30701620]
  36. Am J Prev Med. 2015 Oct;49(4):493-501 [PMID: 26143953]
  37. Am Psychol. 2020 Sep;75(6):811-824 [PMID: 32915025]
  38. JAMA Surg. 2017 Jun 21;152(6):e170504 [PMID: 28403427]
  39. J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):468-75 [PMID: 16601652]
  40. Subst Use Misuse. 2011;46(1):66-76 [PMID: 21190407]
  41. BMC Public Health. 2015 Mar 31;15:244 [PMID: 25886064]
  42. Pain Med. 2016 Feb;17(2):295-303 [PMID: 26235471]
  43. Health Promot Perspect. 2020 Jan 28;10(1):59-65 [PMID: 32104658]
  44. Sci Rep. 2017 Aug 1;7(1):7052 [PMID: 28765624]
  45. Psychiatr Serv. 2013 Feb 1;64(2):165-72 [PMID: 23474608]
  46. Exp Clin Psychopharmacol. 2013 Oct;21(5):385-407 [PMID: 24099359]
  47. J Clin Epidemiol. 2010 Nov;63(11):1179-94 [PMID: 20685078]
  48. Drug Alcohol Depend. 2018 May 01;186:242-256 [PMID: 29626777]
  49. J Am Coll Health. 2020 Aug 11;:1-19 [PMID: 32780647]
  50. MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297 [PMID: 32191688]
  51. Eat Behav. 2014 Apr;15(2):175-81 [PMID: 24854800]
  52. Addict Behav. 2007 Mar;32(3):562-75 [PMID: 16843611]
  53. Drug Alcohol Rev. 2018 Feb;37(2):273-281 [PMID: 28485092]
  54. J Cancer Surviv. 2021 Jan 6;: [PMID: 33405057]
  55. J Addict Med. 2021 Apr 1;15(2):99-108 [PMID: 32769771]
  56. J Subst Abuse Treat. 2016 Sep;68:57-61 [PMID: 27431047]
  57. Neuropsychopharmacology. 2006 May;31(5):1036-47 [PMID: 16160707]
  58. Addict Behav. 2011 Jan-Feb;36(1-2):152-5 [PMID: 20863626]
  59. Am Psychol. 2020 Sep;75(6):772-783 [PMID: 32915022]
  60. J Gen Intern Med. 2011 Dec;26(12):1450-7 [PMID: 21751058]
  61. Addict Behav. 2015 Sep;48:79-88 [PMID: 26042613]
  62. Arch Sex Behav. 2009 Dec;38(6):936-48 [PMID: 18563548]
  63. J Subst Abuse Treat. 2015 Jan;48(1):13-20 [PMID: 25124258]
  64. Drug Alcohol Depend. 2019 Jan 1;194:371-376 [PMID: 30481691]
  65. J Am Coll Health. 2019 Apr;67(3):263-274 [PMID: 29979926]
  66. Am J Addict. 2017 Jun;26(4):379-387 [PMID: 28494131]
  67. Arch Clin Neuropsychol. 2013 Aug;28(5):425-34 [PMID: 23676185]
  68. Psychopharmacology (Berl). 2017 Feb;234(4):621-629 [PMID: 27933366]
  69. Drug Alcohol Depend. 2019 Apr 1;197:73-77 [PMID: 30784951]
  70. Am J Addict. 2018 Dec;27(8):618-624 [PMID: 30328218]
  71. Addict Behav. 2019 Nov;98:106026 [PMID: 31415970]
  72. Anesth Analg. 2017 Nov;125(5):1741-1748 [PMID: 29049118]
  73. J Am Coll Health. 2011;59(5):358-63 [PMID: 21500053]
  74. J Interpers Violence. 2013 Jul;28(11):2315-31 [PMID: 23400885]
  75. Prog Brain Res. 2018;239:1-48 [PMID: 30314565]
  76. Addict Behav. 2015 Mar;42:73-8 [PMID: 25462657]
  77. Medicine (Baltimore). 2019 May;98(20):e15425 [PMID: 31096439]
  78. Pain Physician. 2019 Nov;22(6):E551-E562 [PMID: 31775401]
  79. Prev Med. 2018 Nov;116:112-118 [PMID: 30217407]

Grants

  1. DP2 DA046856/NIDA NIH HHS
  2. UL1 TR002489/NCATS NIH HHS
  3. UL1TR002489/National Center for Advancing Translational Sciences (NCATS), National Institutes of Health
  4. G20RR030883/National Center for Research Resources of the National Institutes of Health
  5. 1DP2DA046856-01/National Institutes of Health Avenir Award
  6. U54GM115677/Institutional Development Award

Word Cloud

Created with Highcharts 10.0.0NMPOstudentsusecollegeprescriptionamongsampleNonmedicalopioidmedicationhelpresearchmisusesubstancefactorsvariousUniversity8%reportedlifetime0historynonmedicalUnitedStatespublichealthcrisisresultinghighratesemergencyroomvisitsmorbiditymortalitypurposestudyexploreprevalenceestimatescorrelatesconveniencenortheastsoutheastregionsUSgeneratedirectionsfutureMotivationsageonsetaccessconcomitantindividualinvestigatedundergraduatetwouniversitiesParticipants=847completedbatteryself-reportmeasuresFindingsrevealed77%Southeastern12Northeasternwhereaspast-month9%participantsrespectivelyLifetimeregularlyusingalcoholbenzodiazepinestimulantssymptomsdepressionanxietyexecutivefunctioningiemetacognitionbehavioralregulationsignificantlyrelatedfindingsofferseveralpotentialsubsequentlinesinvestigationregardingassociationsdemographicpsychologicalFutureneededidentifyriskPrescriptionOpioidUseSampleCollegeStudents:PrevalencePredictors

Similar Articles

Cited By